20 -21 May 2020

MarketsandMarkets Virtual Conference on Liquid Biopsy ( Time Zone - CENTRAL EUROPEAN TIME (CET)

Understanding the potential of liquid biopsies

The advancement of delicate CTC and cfDNA identification led to innovations that has empowered the improvement of liquid biopsies with numerous clinical applications, including-screening for nearness of disease, patient stratification and treatment determination, monitoring treatment reaction and early diagnostics.

MarketsandMarkets Virtual Conference on Liquid Biopsy will unite the pioneers from Diagnostics organization, Experts from Pharmaceutical and Bio-Pharma companies, Researchers and professors from renowned universities to address the challenges in early detection of tumor cells and the potential of liquid biopsies to screen, monitor and treatment of the diseases.

WHAT TO EXPECT
Key Highlights
  • Identification of circulating biomarkers for early diagnosis
  • Challenges and advantages to the end-users
  • Advancement in treatment and monitoring of cancer
  • Clinical and non-clinical application of liquid biopsy
  • Recent developments in assays for liquid biopsy
  • Incorporation of Artificial intelligence and machine learning in liquid biopsy

 

Who Should Attend?

Hospitals- Diagnostics Department, Department of clinical oncology, Pathology Labs

Designation- Oncologist, Immunologist, Hematologist, pathologist, General Practitioners, Lab managers, Lab directors, Medical directors

Universities: Designation- Professors, Researchers, Associate professors in Cancer study

Pharma/Therapeutics: Designation- CEO, COO, Senior scientist in cancer and immunology, Research scientist in cancer, Personalized medicine individuals

Why Attend?
  • Best networking opportunities with industrial experts from all around the world
  • 100+ experts attending
  • Interactive panel discussions with pioneers of the field
  • Platform to showcase/exhibit innovative technologies
  • Expand on existing organizations and make new networks with across industry and the scholarly community
CONFERENCE AGENDA
CONFERENCE SPEAKERS
Speakers
Karl J. DSilva

Karl J. DSilva

Medical Director, Clinical Asst. Professor of Medicine
Tufts University School of Medicine, Lahey Hospitals and Medical Center

Karl J. DSilva

Medical Director, Clinical Asst. Professor of Medicine
Tufts University School of Medicine, Lahey Hospitals and Medical Center
Dana E. Connors

Dana E. Connors

Senior Scientific Project Manager
Cancer Foundation for the National Institutes of Health

Dana E. Connors

Senior Scientific Project Manager
Cancer Foundation for the National Institutes of Health
Dr Emmanouil Karteris

Dr Emmanouil Karteris

Head
CBCEL, London

Dr Emmanouil Karteris

Head
CBCEL, London
Antony Newton

Antony Newton

VP Business Development
Inivata

Antony Newton

VP Business Development
Inivata
DR CATHERINE ALIXPANABIÈRES PhD-

DR CATHERINE ALIXPANABIÈRES PhD-

Director of the Laboratory Rare Circulating Human Cells (LCCRH)
l’Université et CHU de Montpellier, France, Europe

DR CATHERINE ALIXPANABIÈRES PhD-

Director of the Laboratory Rare Circulating Human Cells (LCCRH)
l’Université et CHU de Montpellier, France, Europe
Jennifer Whittington

Jennifer Whittington

Surgical Oncologist
Queens Hospital Cancer Center

Jennifer Whittington

Surgical Oncologist
Queens Hospital Cancer Center
Dr. Harsha Doddihal

Dr. Harsha Doddihal

Clinical researcher, Oncologist
Fortis Hospital

Dr. Harsha Doddihal

Clinical researcher, Oncologist
Fortis Hospital
YOUHE GAO

YOUHE GAO

Professor Department of Biochemistry and Molecular Biology,
Beijing Normal University

YOUHE GAO

Professor Department of Biochemistry and Molecular Biology,
Beijing Normal University
SPONSORS
Sponsors & Exhibitors
example-image

Indivumed

Leading Partner
example-image

Inivata

example-image

RaDar

PAST EVENT GALLERY